A Less Intensive Combination of Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer Patients who Have Aged 60 Years or More and Has a Poor Performance Status

BACKGROUND: The aim of this study was to evaluate the response, survival, and toxicities of a less intensive combination of paclitaxel and carboplatin, which is used in advanced non-small cell lung cancer (NSCLC) patients older than 60 years of age including those with a poor performance status. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Young Joo, Ahn, Jong Joon, Noh, Young Ju, Cha, Hee Jeong, Suh, Jae Hee, Jung, Jong Pil, Park, Chang Ryul, Jeong, Ae Kyung, Park, Jae Hoo, Lee, Ki Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531593/
https://www.ncbi.nlm.nih.gov/pubmed/15366642
http://dx.doi.org/10.3904/kjim.2004.19.2.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531593/
https://www.ncbi.nlm.nih.gov/pubmed/15366642
http://dx.doi.org/10.3904/kjim.2004.19.2.109

Ejemplares similares